A citation-based method for searching scientific literature

Howard I Scher, Karim Fizazi, Fred Saad, Mary-Ellen Taplin, Cora N Sternberg, Kurt Miller, Ronald de Wit, Peter Mulders, Kim N Chi, Neal D Shore, Andrew J Armstrong, Thomas W Flaig, Aude Fléchon, Paul Mainwaring, Mark Fleming, John D Hainsworth, Mohammad Hirmand, Bryan Selby, Lynn Seely, Johann S de Bono. N Engl J Med 2012
Times Cited: 3002



M Kirby, C Hirst, E D Crawford. Int J Clin Pract 2011
Times Cited: 439




List of shared articles



Times cited

Upregulation of PSMA Expression by Enzalutamide in Patients with Advanced mCRPC.
Florian Rosar, Robert Neher, Caroline Burgard, Johannes Linxweiler, Mathias Schreckenberger, Manuela A Hoffmann, Mark Bartholomä, Fadi Khreish, Samer Ezziddin. Cancers (Basel) 2022
1

Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer.
Marscha S Holleman, Simone A Huygens, Maiwenn J Al, Malou C P Kuppen, Hans M Westgeest, Alfonsus C M van den Bergh, Andries M Bergman, Alfonsus J M van den Eertwegh, Mathijs P Hendriks, Menuhin I Lampe,[...]. Drugs Real World Outcomes 2022
0


Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer.
Hirotaka Kazama, Osamu Kawaguchi, Takeshi Seto, Kazuhiro Suzuki, Hideyasu Matsuyama, Nobuaki Matsubara, Yuki Tajima, Taro Fukao. BMC Cancer 2022
0

Early molecular imaging response assessment based on determination of total viable tumor burden in [68Ga]Ga-PSMA-11 PET/CT independently predicts overall survival in [177Lu]Lu-PSMA-617 radioligand therapy.
Florian Rosar, Felix Wenner, Fadi Khreish, Sebastian Dewes, Gudrun Wagenpfeil, Manuela A Hoffmann, Mathias Schreckenberger, Mark Bartholomä, Samer Ezziddin. Eur J Nucl Med Mol Imaging 2022
3

Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial.
Thomas Powles, Kobe C Yuen, Silke Gillessen, Edward E Kadel, Dana Rathkopf, Nobuaki Matsubara, Charles G Drake, Karim Fizazi, Josep M Piulats, Piotr J Wysocki,[...]. Nat Med 2022
14

Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer.
Mahasha P J Perera, Patrick B Thomas, Gail P Risbridger, Renea Taylor, Arun Azad, Michael S Hofman, Elizabeth D Williams, Ian Vela. Cancers (Basel) 2022
2